$55.14
+7.5%PDF Solutions, Inc. provides proprietary software and physical intellectual property products for integrated circuit designs, electrical measurement hardware tools, proven methodologies, and professional services in the United States, China, Japan, Taiwan, and internationally. The company offers Exensio software products, such as Manufacturing Analytics that stores collected data in a common environment with a consistent view for enabling product engineers to identify and analyze production yield, performance, reliability, and other issues; Process Control that provides failure detection and classification capabilities for monitoring, alarming, and controlling manufacturing tool sets; Test Operations that offers data collection and analysis capabilities; and Assembly Operations that provides device manufacturers with the capability to link assembly and packaging data, including fabrication and characterization data over the product life cycle. It also provides design-for-inspection (DFI) Systems, such as DFI on-chip instruments; eProbe non-contactless E-beam tool; and Characterization Vehicle (CV) system, which includes CV test chips and pdFasTest electrical testers, as well as Exensio characterization software, designed to analyze the measurements collected from DFI on-chip instruments using the eProbe tool. In addition, the company offers Cimetrix software products that enables equipment manufacturers to provide industry standard interfaces on their products; and software-as-a-service, software related services, and characterization services. It sells its technologies and services through direct sales force, service teams, and strategic alliances to integrated device manufacturers, fabless semiconductor companies, foundries, equipment manufacturers, electronics manufacturing suppliers, original device manufacturers, out-sourced semiconductor assembly and test, and system houses. The company was founded in 1991 and is headquartered in Santa Clara, California.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
PDFS โข NASDAQ
| PDF Solutions, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
-640K | 4.1M | 3.1M | -3.4M | -21.5M | -40.4M | -5.4M | -7.7M | -1.3M | 9.1M | 12.4M | 18.5M | 20.9M | 37.2M | 1.9M | 227K | -17.5M | -95.7M | -2.9M | -439K | |
11.3M | 6.9M | 8.5M | 9M | 9.6M | 8.2M | 7.2M | 6M | 5.7M | 4.4M | 3M | 2M | 1.5M | 949K | 1.3M | 2.4M | 3.2M | 5.3M | 10.7M | 8.8M | |
895K | -74K | -108K | -4K | 1.4M | 21M | -4.5M | -4.2M | -504K | 216K | 848K | 4.6M | 5.9M | -19.9M | 21K | -527K | 16.9M | 2.6M | -5.5M | -6.9M | |
25.9M | 25M | 21.5M | 19.6M | 12.9M | 12.5M | 11.4M | 10.3M | 11.8M | 11M | 9.8M | 8.5M | 6.7M | 4.9M | 4.8M | 5.2M | 4.3M | 7.2M | 8.2M | 7.4M | |
2.1M | 4.1M | 770K | 1.4M | 4M | 1M | 614K | 369K | 153K | -39K | -602K | -1.5M | -1.6M | -458K | -652K | -583K | -17.5M | 70.8M | 164K | 1.5M | |
(0.0) | (2.6M) | (3.8M) | (2.9M) | (1.9M) | (2.7M) | (2.7M) | (2.6M) | (2.2M) | (3.6M) | (5M) | (4.2M) | (4.7M) | (1.7M) | (2.1M) | (2.1M) | (1.6M) | (2.4M) | (634K) | (0.0) | |
-15.6M | -30.3M | -19.2M | 5.7M | -2.1M | 19.5M | 15.3M | 8.6M | -5.2M | -22.7M | 3.1M | -5.1M | -8M | -7.9M | 884K | -4M | 6M | 17.4M | -9.3M | -7.8M | |
24.1M | 9.7M | 14.6M | 32.3M | 4.2M | 21.8M | 24.6M | 13.3M | 10.5M | 2M | 28.5M | 27.1M | 25.4M | 14.8M | 8.2M | 2.7M | -4.6M | 7.6M | 1.4M | 2.6M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-32.6M | -17.2M | -11.3M | -8.6M | -4.1M | -7M | -10.6M | -13.1M | -10.3M | -11.3M | -5.2M | -4M | -4.6M | -2.3M | -405K | -121K | -569K | -1.1M | -2.2M | -2.4M | |
-129.7M | (0.0) | -1.8M | (171K) | -3.1M | -28.6M | -2.7M | (0.0) | -3.8M | (0.0) | -5.2M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1.6M | -4.6M | -18.7M | |
-2.9M | -54.3M | -59.6M | -58.3M | -168.6M | -131.5M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -27.1M | -26.8M | -45.8M | |
27.5M | 68.1M | 43.8M | 151.5M | 171M | 16.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 975K | 0.0 | 0.0 | 9.1M | 26.9M | 33.8M | 31.7M | |
427K | -2.6M | -45K | -171K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -400K | 285K | 0.0 | 975K | 0.0 | 0.0 | 0.0 | 0.0 | -4.6M | -18.7M | |
-137.4M | -5.9M | -29M | (84.6M) | -4.7M | -150.5M | -13.2M | -13.1M | -14.1M | -11.3M | -10.3M | -3.7M | -4.6M | -1.4M | -405K | -121K | (8.5M) | -2.9M | (203K) | -35.2M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
4M | -6.9M | -743K | -22.5M | -4.5M | 65.1M | -9.6M | -5.2M | -13.4M | -2.2M | -14.5M | -3.6M | 0.0 | -4.4M | -2.9M | 0.0 | 570K | -6.3M | -4.5M | 7.8M | |
66.8M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -347K | 0.0 | 0.0 | 0.0 | -112K | -107K | -267K | -409K | -740K | -23K | |
-244K | -6.9M | -743K | -22.5M | -4.5M | (0.0) | -9.6M | -5.2M | -13.4M | -2.2M | -14.5M | -3.6M | -1.3M | -4.4M | -2.9M | (0.0) | (0.0) | -6.9M | -6M | (0.0) | |
-6.2M | -4.3M | -5.1M | -1.8M | -1M | -280K | -196K | 46K | 1.2M | 4.5M | 7.5M | 7.9M | 7M | 6.6M | 3.2M | 833K | 0.0 | 63K | 1.5M | 463K | |
64.6M | -11.2M | -5.9M | -24.3M | -5.5M | 64.8M | -9.8M | -5.2M | -12.2M | 30K | -7.4M | 2.7M | 7M | 2.3M | 108K | 726K | 303K | -6.6M | -3.7M | 8.2M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
371K | -918K | -365K | -650K | -182K | 131K | -27K | -198K | 255K | -119K | -76K | -54K | -10K | -51K | -29K | -75K | -972K | -1.7M | 1M | 319K | |
-48.4M | -8.4M | -20.6M | 91.9M | -6.1M | -63.8M | 1.5M | -5.2M | -15.5M | -9.4M | 10.7M | 26.1M | 27.7M | 15.6M | 7.9M | 3.3M | 3.2M | -3.6M | -1.1M | -24.1M | |
90.6M | 99M | 119.6M | 27.7M | 33.8M | 97.6M | 96.1M | 101.3M | 116.8M | 126.2M | 115.5M | 89.4M | 61.6M | 46M | 38.2M | 34.9M | 31.7M | 35.3M | 36.5M | 60.5M | |
42.2M | 90.6M | 99M | 119.6M | 27.7M | 33.8M | 97.6M | 96.1M | 101.3M | 116.8M | 126.2M | 115.5M | 89.4M | 61.6M | 46M | 38.2M | 34.9M | 31.7M | 35.3M | 36.5M | |
-8.6M | -7.5M | 3.1M | 23.7M | 190K | 14.8M | 14M | 222K | 290K | -9.3M | 23.3M | 23.1M | 20.7M | 12.4M | 7.8M | 2.6M | -5.2M | 6.4M | -856K | 194K |
PDFS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 15, 2026 | May 13, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 24, 2026 | April 23, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 24, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 12, 2026 | February 12, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 13, 2025 | November 12, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 |
Continue your PDFS research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.